End COVID-19 in low- and middle-income countries
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Description
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
An evidence review of face masks against COVID-19
Howard, J., Huang, A., Li, Z., Tufekci, Z., Zdimal, V., van der Westhuizen, H.-M., von Delft, A., Price, A., Fridman, L., Tang, L.-H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014564118 · Cited by 1,529
COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries
(2021) · doi:10.1038/s41591-021-01454-y · Cited by 1,105
Self-citationGrimm, P. (2010) · Wiley International Encyclopedia of Marketing · doi:10.1002/9781444316568.wiem02057 · Cited by 1,054
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
Neumann-Böhme, S., Varghese, N. E., Sabat, I., Barros, P. P., Brouwer, W., van Exel, J., Schreyögg, J., & Stargardt, T. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01208-6 · Cited by 1,011
Social Protection and Jobs Responses to COVID-19: A Real-Time Review of Country Measures
Almenfi, M., Gentilini, U., Orton, I., & Dale, P. (2020) · World Bank, Washington, DC eBooks · doi:10.1596/33635 · Cited by 619
The role of co-infections and secondary infections in patients with COVID-19
Feldman, C., & Anderson, R. (2021) · Pneumonia · doi:10.1186/s41479-021-00083-w · Cited by 319
Abedin, M., Islam, M. A., Rahman, F. N., Reza, H. M., Hossain, M. Z., Hossain, M. A., Arefin, A., & Hossain, A. (2021) · PLOS ONE · doi:10.1371/journal.pone.0250495 · Cited by 233
Self-citationGandhi, M., Beyrer, C., & Goosby, E. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06067-8 · Cited by 214
Social Protection and Jobs Responses to COVID-19: A Real-Time Review of Country Measures
Gentilini, U., Almenfi, M. B. A., Iyengar, T., Okamura, Y., Downes, J. A., Dale, P., Weber, M., Newhouse, D. L., Rodriguez Alas, C. P., Kamran, M., et al. (2022) · World Bank, Washington, DC eBooks · doi:10.1596/37186 · Cited by 184
Impact of COVID-19 on cancer care in India: a cohort study
Ranganathan, P., Sengar, M., Chinnaswamy, G., Agrawal, G., Arumugham, R., Bhatt, R., Bilimagga, R., Chakrabarti, J., Chandrasekharan, A., Chaturvedi, H. K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00240-0 · Cited by 159
Research works printed but not linked: 10
- D. Egger Sci. Adv. 10.1126/sciadv.abe0997 (2021). · DOI · Paper page
- E. Miguel, A. M. Mobarak, “The economics of the COVID-19 pandemic in poor countries,” NBER Working Paper 29339, National Bureau of Economic Research, October 2021.
- U. Arora J. Infect. 10.1016/j.jinf.2021.12.039 (2021). · DOI
- J. A. Lewnard Lancet Infect. Dis. 10.1016/S1473-3099(21)00746-5 (2021). · DOI · Paper page
- K. Kupferschmidt Science 10.1126/science.abe0601 (2020). · DOI
- A. Ahuja , AEA Pap. Proc. 111, 331–35 (2021).
- A. Alatas , “When celebrities speak: A nationwide Twitter experiment promoting influenza vaccination,” NBER Working Paper 25589, National Bureau of Economic Research, February 2019.
- A. Banerjee , “Messages on COVID-19 prevention in India increases symptoms reporting and adherence to preventive behaviors among 25 million recipients with similar effects on non-recipient members of their community,” NBER Working Paper 27496, National Bureau of Economic Research, August 2020.
- J. Abaluck , Science 375, 6577 (2021).
- D. Egger medRxiv 10.1101/2022.02.16.22270815 (2022). · DOI
Cited by
Global disparities in SARS-CoV-2 genomic surveillance
Brito, A. F., Semenova, E., Dudas, G., Hassler, G. W., Kalinich, C. C., Kraemer, M. U. G., Ho, J., Tegally, H., Githinji, G., Agoti, C. N., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33713-y · Cited by 284
Barriers and facilitators of HPV vaccination in sub-saharan Africa: a systematic review
Kutz, J.-M., Rausche, P., Gheit, T., Puradiredja, D. I., & Fusco, D. (2023) · BMC Public Health · doi:10.1186/s12889-023-15842-1 · Cited by 204
“Once the bottleneck of dose availability was unblocked because of increased production and the decreasing demand of high-income countries, many SSA countries were not in the position to cope with the in-country distribution costs to achieve the required vaccine coverage [77, 78].”
BackgroundEstimating the impact of COVID-19 vaccine inequities: a modeling study
Gozzi, N., Chinazzi, M., Dean, N. E., Longini, I. M., Halloran, M. E., Perra, N., & Vespignani, A. (2023) · Nature Communications · doi:10.1038/s41467-023-39098-w · Cited by 116
A deep learning approach for classification of COVID and pneumonia using DenseNet ‐201
Sanghvi, H. A., Patel, R. H., Agarwal, A., Gupta, S., Sawhney, V., & Pandya, A. S. (2022) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.22812 · Cited by 122
“Omicron has been detected in over 20 countries across six continents.(10) The first step in comprehending Omicron's common or unmistakable clinical aggregation, affectability, or protection from existing vaccinations is to fully describe its mutational profile.”
BackgroundVaccine access, equity and justice: COVID-19 vaccines and vaccination
Privor-Dumm, L. A., Excler, J., Gilbert, S. E., Karim, S. S. A., Hotez, P. J., Thompson, D., & Kim, J. H. (2023) · BMJ Global Health · doi:10.1136/bmjgh-2023-011881 · Cited by 113
The impact of delayed access to COVID-19 vaccines in low- and lower-middle-income countries
Duroseau, B., Kipshidze, N. N., & Limaye, R. J. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1087138 · Cited by 87
A systematic review and meta-analysis of strategies to promote vaccination uptake
Liu, S., Durantini, M. R., Calabrese, C., Sánchez, F., & Albarracín, D. (2024) · Nature Human Behaviour · doi:10.1038/s41562-024-01940-6 · Cited by 55
“In rural Sierra Leone, for example, citizens who live on US$1.50 a day must spend about US$13 on transportation to vaccinate in the nearest clinic 74 .”
BackgroundInfluentialAssessing COVID-19 vaccine hesitancy and barriers to uptake in Sub-Saharan Africa
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2023) · Communications Medicine · doi:10.1038/s43856-023-00330-9 · Cited by 47
“High opportunity costs to accessing vaccines and local supply constraints also resonate with recent calls for more vaccine equity and an expansion of domestic vaccine manufacturing capacity in the region 6,7,17,37,38,41,43 – 46 .”
BackgroundLast-mile delivery increases vaccine uptake in Sierra Leone
Meriggi, N. F., Voors, M., Levine, M., Ramakrishna, V., Kangbai, D. M., Rozelle, M., Tyler, E., Kallon, S., Nabieu, J., Cundy, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07158-w · Cited by 36
“In the results Extended Data Tables 3, 4, 6 and 7, we also adjust for the fact that we conduct multiple tests on the same dataset by implementing false discovery rate (FDR) corrections and report the FDR q-values.”
MethodSelf-citationWhy are vaccination rates lower in low and middle income countries, and what can we do about it?
Reza, H. M., Agarwal, V., Sultana, F., Bari, R., & Mobarak, A. M. (2022) · BMJ · doi:10.1136/bmj-2021-069506 · Cited by 30
Self-citationKandeel, A., ELdeyahy, I., Elsood, H. A., Fahim, M., Afifi, S., Kamar, S. A., BahaaEldin, H., Ahmed, E., Mohsen, A. M., & Abdelghaffar, K. (2023) · BMC Public Health · doi:10.1186/s12889-023-15283-w · Cited by 31
“Apart from operational challenges, vaccine hesitancy is a serious problem that could be caused by fear of side effects, lack of information and misinformation about vaccination, and distrust of government and pharmaceutical companies [5].”
BackgroundThe Vaccine World of COVID-19: India’s Contribution
Chavda, V. P., Vihol, D. R., Solanki, H. K., & Apostolopoulos, V. (2022) · Vaccines · doi:10.3390/vaccines10111943 · Cited by 31
The evolution of COVID-19 vaccine hesitancy in Sub-Saharan Africa: evidence from panel survey data
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2023) · BMC Proceedings · doi:10.1186/s12919-023-00266-x · Cited by 25
“Following the availability of COVID-19 vaccines, the severity of the pandemic that ensued over the course of 2020 has also put time pressure on the rollout of vaccination campaigns, has led to supply shortages and resulted in vastly heterogeneous availability of COVID-19 vaccines across the globe [7].”
BackgroundGrieve, R., Yang, Y., Abbott, S., Babu, G. R., Bhattacharyya, M., Dean, N. E., Evans, S. J. W., Jewell, N. P., Langan, S., Lee, W., et al. (2023) · PLOS Global Public Health · doi:10.1371/journal.pgph.0002601 · Cited by 27
“These three themes are distinct from previous reflections [1–6] and were judged of prime importance, particularly for nimble data-driven policy-making towards timely outbreak control.”
BackgroundAmeratunga, R., Leung, E., Woon, S., Chan, L., Steele, R., Lehnert, K., & Longhurst, H. (2022) · Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.06.011 · Cited by 14
“Hundreds of millions of individuals have been plunged into abject poverty caused by economic misery in developing countries.(1) The economic gains of the last decade or longer have been reversed by the pandemic in some nations.”
BackgroundBehavioral Changes Associated With COVID-19 Vaccination: Cross-National Online Survey
Gaetano, A. D., Bajardi, P., Gozzi, N., Perra, N., Perrotta, D., & Paolotti, D. (2023) · Journal of Medical Internet Research · doi:10.2196/47563 · Cited by 18
Epidemiological Trends of Coronavirus Disease 2019 in Sierra Leone From March 2020 to October 2021
Liu, Z., Gao, L., Xue, C., Zhao, C., Liu, T., Tia, A. B., Wang, L., Sun, J., Li, Z., & Harding, D. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.949425 · Cited by 13
“However, when COVID-19 mortality rates are high and health systems are strained, masks can potentially save many lives at a low cost (33).”
BackgroundSophonmanee, R., Ongarj, J., Seeyankem, B., Seepathomnarong, P., Intapiboon, P., Surasombatpattana, S., Uppanisakorn, S., Sangsupawanich, P., Chusri, S., & Pinpathomrat, N. (2022) · Vaccines · doi:10.3390/vaccines10091494 · Cited by 13
“Many low- and middle-income countries still have limited access to COVID-19 vaccines; therefore, fractional vaccination could be a reasonable option for increasing vaccine coverage [29,30].”
BackgroundGheinari, F. M., Sakhaee, F., Gholami, M., Sotoodehnejadnematalahi, F., Zamani, M. S., Ahmadi, I., Anvari, E., & Fateh, A. (2022) · Disease Markers · doi:10.1155/2022/5988976 · Cited by 13
Liang, Y., & Sun, Y. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2286686 · Cited by 15
“39 The COVID-19 Vaccines Global Access (COVAX) facility, founded in April 2020, was committed to providing equitable vaccine access for people in LMICs, but the vaccination rates were still not satisfactory in these countries until 2022.”
BackgroundKim, J., Kim, D., Baek, K., Kim, M., Kang, B. M., Maharjan, S., Park, S., Choi, J.-K., Kim, S., Kim, Y. K., et al. (2022) · Viruses · doi:10.3390/v15010028 · Cited by 11
COVID-19 vaccine express strategy in Malawi: An effort to reach the un-reach
Sethy, G., Chisema, M., Sharma, L., Joshi, K., Singhal, S., Nicks, P. O., Macheso, S., Damte, T., Ba, A. E., Mitambo, C., et al. (2022) · Vaccine · doi:10.1016/j.vaccine.2022.07.014 · Cited by 10
COVID-19 information and self-protective behaviors among rural communities in tropical forests
Takasaki, Y., Coomes, O. T., & Abizaid, C. (2022) · BMC Public Health · doi:10.1186/s12889-022-13772-y · Cited by 10
Comparative Analysis of SARS-CoV-2 Antibody Responses across Global and Lesser-Studied Vaccines
Zambrana, J. V., Saenz, C., Maier, H. E., Brenes, M., Nunez, A. C., Matamoros, A., Hernández, M., Dumas, K., Toledo, C., Peralta, L., et al. (2024) · Vaccines · doi:10.3390/vaccines12030326 · Cited by 6
“Initially Initially, in late 2020, most low-and middle-income countries, like Nicaragua [10], lacked access to these vaccines.”
BackgroundEstimating the impact of COVID-19 vaccine allocation inequities: a modeling studyPreprint
Gozzi, N., Chinazzi, M., Dean, N. E., Longini, I. M., Halloran, M. E., Perra, N., & Vespignani, A. (2022) · medRxiv · doi:10.1101/2022.11.18.22282514 · Cited by 8
“This figure clearly highlights the different logistic challenges in setting up a mass vaccination campaign across countries and speaks to the differential power among income levels to secure a scarce resource such as COVID-19 vaccines in the early phases of the rollout [19].”
Transforming Pediatric Global Health Education Through Antiracist and Anticolonial Principles
Fanny, S. A., Tam, R. P., Rule, A. R. L., Barnes, A., & Haq, H. A. (2024) · PEDIATRICS · doi:10.1542/peds.2023-062612 · Cited by 7
COVID-19 contagion across remote communities in tropical forests
Takasaki, Y., Abizaid, C., & Coomes, O. T. (2022) · Scientific Reports · doi:10.1038/s41598-022-25238-7 · Cited by 8
Cost effectiveness of fractional doses of COVID-19 vaccine boosters in India
Du, Z., Wang, L., Bai, Y., Feng, S., Ramachandran, S., Lim, W. W., Lau, E. H. Y., Malani, A., & Cowling, B. J. (2023) · Med · doi:10.1016/j.medj.2023.02.001 · Cited by 7
“Although vaccine-derived immunity is expected to wane quickly, vaccines have changed the course of the COVID-19 pandemic.(20) However, a highly vaccinated population is still not enough to combat Omicron’s spread, as variants have been able to escape the immunity conferred by vaccinations or prior infections.”
Nomura, S., Ghaznavi, C., Shimizu, K., Cao, A. Q., Sassa, M., Uchibori, M., Rauniyar, S. K., Yamasaki, L., Tomoi, H., & Sakamoto, H. (2023) · Global Health Action · doi:10.1080/16549716.2023.2258707 · Cited by 6
“Beyond immediate healthcare needs, the pandemic has disrupted economic activities and exhausted government revenue [7].”
BackgroundWang, T., Xu, J., Wang, B., Wang, Y., Zhao, W., Xiang, B., Xue, Y., Yuan, Q., & Wang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.910343 · Cited by 3
“While vaccinations and natural infections build herd immunity that helps to protect people from infection or prevent pandemic recurrence (Lipsitch and Dean, 2020; Mobarak et al., 2022), cures are still lacking for the infected individuals in most areas.”
BackgroundOlugemo, K., Bugarski‐Kirola, D., Dawson, G. R., DiCesare, F., Stevanović, D., Samardžić, J., Chatzittofis, A., Moore, R. C., Verster, J. C., Bhering, L., et al. (2023) · Neuroscience Applied · doi:10.1016/j.nsa.2023.101129 · Cited by 3
“Ahuja and Mobarak (2022) highlighted the ability of LMICs researchers to rapidly conduct trials and surveys in community settings at a large scale during COVID-19 and combine tools from public health and social sciences to understand the interaction of the disease and social environments (Mobarak…”
Turning COVID-19 Vaccines into Vaccinations: New Evidence from Sub-Saharan Africa
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2022) · World Bank, Washington, DC eBooks · doi:10.1596/1813-9450-10152 · Cited by 3
Chronic Poverty Report 5 - Pandemic Poverty
Shepherd, A., & Diwakar, V. (2023) · OpenDocs (Institute of Development Studies) · doi:10.19088/cc.2023.006 · Cited by 6
Highlighting the Need for MD-PhD Programs in Developing Countries
Ashour, L., Schoumann-Alkhatib, A., Alshawabkeh, A., Alsouri, M., Sawalmeh, M., Hatamleh, H., & Sawahreh, H. (2023) · Avicenna Journal of Medicine · doi:10.1055/s-0043-1768445 · Cited by 4
Huang, X., Kong, Q.-Y., Wan, X., Huang, Y., Wang, R., Wang, X., Li, Y., Wu, Y., Guan, C., Wang, J., et al. (2024) · JMIR Public Health and Surveillance · doi:10.2196/55194 · Cited by 2
“To address the current gaps in pre-epidemic surveillance and prevention, Mobarak et al [10] suggest creating a relatively complete and locally relevant general detection system, including individual and population-wide engagement strategies, in areas where the basic public health system lags…”
BackgroundA longitudinal mixed effects model for assessing mortality trends during vaccine rollout
Shao, Q., Polavarapu, M., Small, L., Singh, S., Nguyen, Q., & Shao, K. (2024) · Healthcare Analytics · doi:10.1016/j.health.2024.100347 · Cited by 3
Mobarak, A. M. (2023) · AEA Papers and Proceedings · doi:10.1257/pandp.20231109 · Cited by 2
Self-citationSethy, G., Chisema, M., Sharma, L., Joshi, K., Singhal, S., Nicks, P. O., Macheso, S., Damte, T., Ba, A. E., Mitambo, C., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4094796 · Cited by 2
Fadel, E. A., Alshawish, E., El-Shaboury, R. H. R., Khalil, D., Mahmoud, F. Z., & El-Feshawy, N. I. (2025) · INQUIRY The Journal of Health Care Organization Provision and Financing · doi:10.1177/00469580251339114 · Cited by 4
“21,22 Eradicating vaccine misconceptions among nursing students is vital in the interest of public health because the group of nursing students is expected to become future professional nurses and patient educators.”
Estimating behavioural relaxation induced by COVID-19 vaccines in the first months of their rollout
Li, Y., Gozzi, N., & Perra, N. (2025) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013266 · Cited by 1
“Our findings confirm that both vaccinations and NPIs significantly reduced infection and mortality rates.”
Cardoso, N. D. O., Machado, W. D. L., & Guilherme, A. A. (2026) · Trends in Psychology · doi:10.1007/s43076-026-00519-6 · Cited by 2
Tropical forest environments provide insurance against COVID-19
Takasaki, Y., Coomes, O. T., & Abizaid, C. (2023) · Ecology and Society · doi:10.5751/es-14349-280308 · Cited by 2
Navigating the Aftermath: The Complex Landscape of COVID-19 in Northwest Syria
Al-Abdulla, O., & Alaref, M. (2023) · Journal of Health Systems and Policies · doi:10.52675/jhesp.1342517 · Cited by 1
Bick, S., White, S., Thorseth, A. H., Friedrich, M., Gavin, I., Gautam, O. P., & Dreibelbis, R. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-082419 · Cited by 3
“Future research should focus on gender- non-conforming individuals and explore how pandemic responses include and address their needs.”
BackgroundNdishimye, P., Martinez, G. S., Hewins, B., Ostadgavahi, A. T., Kumar, A., Sharma, M., Karuhije, J., Nkeshimana, M., Nsanzimana, S., & Kelvin, D. J. (2023) · medRxiv · doi:10.1101/2023.03.05.23286509 · Cited by 1
“Ensuring that the COVID-19 vaccine remains easily accessible to everyone and everywhere is the most promising solution to end this pandemic (Wible, 2022).”
BackgroundMakram, A. M., Tran, V. P., Elsheikh, R., Hau, N. T. H., Gani, S. M. A., & Huy, N. T. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2129233
Technology adoption and institutions : Evidence from field experiments in Cameroon
Meriggi, N. F. (2022) · doi:10.18174/579103
Self-citationHow to control the spatiotemporal spread of Omicron in the region with low vaccination rates
Tong, C., Shi, Z., Shi, W., & Zhang, A. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.959076
Aizenman, A., Conteh, F. E., Glennerster, R., Horn, S., Kangbai, D. M., Karing, A., & Shaukat, S. (2023) · AEA Papers and Proceedings · doi:10.1257/pandp.20231111
Bibliography, Chronic Poverty Report 5 - Pandemic Poverty
Shepherd, A., & Diwakar, V. (2023) · OpenDocs (Institute of Development Studies) · doi:10.19088/cpan.2023.022
Hasan, T., Ahmed, M. K., Alman, K. A., Rashid, M., Muhib, F., Rahman, S., Noor, N., Islam, M. K., Chowdhury, F. U. H., Sharif, M., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3279902/v1
COVID-19 in Bangladesh as an Example of the World Region South Asia
Khan, M. M. H. (2023) · Medizin, Kultur, Gesellschaft · doi:10.1007/978-3-658-40525-0_19
Bick, S., White, S., Thorseth, A. H., Friedrich, M., Gavin, I., Gautam, O. P., & Dreibelbis, R. (2023) · medRxiv · doi:10.1101/2023.11.03.23298032
Press freedom and stringency measures: the role of energy consumption during COVID-19 lockdowns
Bhattacharya, M., & Yan, E. W. C. (2025) · Empirical Economics · doi:10.1007/s00181-025-02722-3
Long-Term Mental Health Impact of COVID-19 on Pregnant Women in Vietnam
Nguyen, M. N., Tran, H. D., Nguyen, K. N. T., Nguyen, T. D., Hien, H. T. D., Nguyen, T. S. T., Nguyen, A. H. B., & Giau, V. V. (2025) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-031-90197-3_74
Kutz, J.-M., Rausche, P., Gheit, T., Puradiredja, D. I., & Fusco, D. (2024) · Figshare · doi:10.6084/m9.figshare.26592137
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2024) · Figshare · doi:10.6084/m9.figshare.26602570
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2024) · Figshare · doi:10.6084/m9.figshare.26602585
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2024) · Figshare · doi:10.6084/m9.figshare.26602588
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2024) · Figshare · doi:10.6084/m9.figshare.26602573
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2024) · Figshare · doi:10.6084/m9.figshare.26602576
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2024) · Figshare · doi:10.6084/m9.figshare.26602591
Kutz, J.-M., Rausche, P., Gheit, T., Puradiredja, D. I., & Fusco, D. (2024) · Figshare · doi:10.6084/m9.figshare.26592143
Takasaki, Y., Coomes, O. T., & Abizaid, C. (2022) · Figshare · doi:10.6084/m9.figshare.20347559
Kutz, J.-M., Rausche, P., Gheit, T., Puradiredja, D. I., & Fusco, D. (2024) · Figshare · doi:10.6084/m9.figshare.26592140
Kutz, J.-M., Rausche, P., Gheit, T., Puradiredja, D. I., & Fusco, D. (2024) · Figshare · doi:10.6084/m9.figshare.26592146
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2024) · Figshare · doi:10.6084/m9.figshare.26602579
Wollburg, P. R., Markhof, Y. V., Kanyanda, S. S. E., & Zezza, A. (2024) · Figshare · doi:10.6084/m9.figshare.26602582
Gilliss, L., Manhiça, C., Kuo, H., Mulungo, A., Aveika, A. A., Machava, N., Dyk, F. V., Sacoor, C., Monjane, C., Macicame, I., et al. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1484477
Impacts of Social Assistance During the COVID‐19 Pandemic in Poor Remote Communities
Takasaki, Y., Coomes, O. T., & Abizaid, C. (2026) · Journal of International Development · doi:10.1002/jid.70086
Metadata
- Authors
- Mobarak, A. M., Miguel, E., Abaluck, J., Ahuja, A., Alsan, M., Banerjee, A., Breza, E., Chandrasekhar, A. G., Duflo, E., Dzansi, J., Garrett, D., Goldsmith-Pinkham, P., Gonsalves, G. S., Hossain, M. M., Jakubowski, A., Kang, G., Kharel, A., Kremer, M., Meriggi, N., Nekesa, C., Olken, B. A., Omer, S. B., Qadri, F., Rees, H., Salako, B., Voors, M., Warren, S., & Więcek, W.
- Affiliations
- Yale University (US)
- Center for Effective Global Action (US)
- Douglas B. Marshall Jr. Family Foundation (US)
- Harvard University (US)
- Massachusetts Institute of Technology (US)
- Stanford University (US)
- International Growth Centre, Accra, Ghana.
- Sabin Vaccine Institute (US)
- North South University, Dhaka, Bangladesh.
- Christian Medical College, Vellore (IN)
- Tribhuvan University (NP)
- University of Chicago (US)
- International Growth Centre, Freetown, Sierra Leone.
- Remit Kenya (Kenya) (KE)
- International Centre for Diarrhoeal Disease Research (BD)
- University of the Witwatersrand (ZA)
- Nigerian Institute of Medical Research (NG)
- Wageningen University & Research (NL)
- Innovations for Poverty Action (US)
- ORCID
- Mobarak, Ahmed Mushfiq
- Miguel, Edward
- Abaluck, Jason
- Alsan, Marcella
- Banerjee, Abhijit
- Breza, Emily
- Duflo, Esther
- Dzansi, James
- Garrett, Denise
- Goldsmith-Pinkham, Paul
- Gonsalves, Gregg S.
- Jakubowski, Aleksandra
- Kang, Gagandeep
- Kharel, Arjun
- Kremer, Michael
- Olken, Benjamin A.
- Omer, Saad B.
- Qadri, Firdausi
- Rees, Helen
- Salako, Babatunde
- Voors, Maarten
- Warren, Shana
- Więcek, Witold
- Venue
- Science
- Published
- 2022-03-11
- Volume
- 375
- Issue
- 6585
- Pages
- 1105-1110
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4220667493
- Cited by
- 68
- References
- 32
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 19 · 2023: 24 · 2022: 18
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- green
- research.wur.nl
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Socio-Environmental Systems Modeling (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (VI.Vidi.191.154)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Keywords
- COVID-19 pandemic, low- and middle-income countries, pandemic response, global health equity, health system capacity
- MeSH terms
- Vaccination Coverage, Cell Phone Use, COVID-19, COVID-19 Vaccines, Vaccination Hesitancy, Communicable Disease Control, Developing Countries, Humans, India, Masks, Biomedical Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.